Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02749903
What this trial is testing

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

Who this might be right for
Salivary Cancer
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT01875250
What this trial is testing

Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT05549778
What this trial is testing

Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Jiangnan University 12
Not applicableStudy completedNCT05362149
What this trial is testing

An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings

Who this might be right for
Non-metastatic Castration-resistant Prostate Cancer
Bayer 870
Testing effectiveness (Phase 2)Study completedNCT01867333
What this trial is testing

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT05520138
What this trial is testing

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 5,506
Early research (Phase 1)Study completedNCT02125084
What this trial is testing

Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 38
Not applicableStudy completedNCT05968599
What this trial is testing

Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 2,731
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07104643
What this trial is testing

Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

Who this might be right for
mCRPC
TYK Medicines, Inc 48
Post-approval studies (Phase 4)Active Not RecruitingNCT04597125
What this trial is testing

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Bayer 654
Testing effectiveness (Phase 2)Study completedNCT02090114
What this trial is testing

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 112
Testing effectiveness (Phase 2)Study completedNCT02091960
What this trial is testing

Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Who this might be right for
HER2 AmplifiedAdvanced Breast CancerHuman Epidermal Growth Factor Receptor 2 (HER2)
Astellas Pharma Global Development, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT02064582
What this trial is testing

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 7
Not applicableStudy completedNCT03328364
What this trial is testing

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma a/s 211
Testing effectiveness (Phase 2)Study completedNCT02430480
What this trial is testing

Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT03834519
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 793
Early research (Phase 1)Study completedNCT02339168
What this trial is testing

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 25
Testing effectiveness (Phase 2)Study completedNCT02225704
What this trial is testing

Radium-223 in Combination With Enzalutamide

Who this might be right for
Prostate Cancer
Cancer Trials Ireland 45
Early research (Phase 1)Looking for participantsNCT06576037
What this trial is testing

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Who this might be right for
Solid Tumor
M.D. Anderson Cancer Center 128
Early research (Phase 1)Looking for participantsNCT06257693
What this trial is testing

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Alessa Therapeutics Inc. 45
Next Page